triethylenemelamine has been researched along with Autoimmune Disease in 2 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| TAYLOR, L | 1 |
| BERENBAUM, MC | 1 |
| BROWN, IN | 1 |
2 other studies available for triethylenemelamine and Autoimmune Disease
| Article | Year |
|---|---|
IDIOPATHIC AUTOIMMUNE HEMOLYTIC ANEMIA. RESPONSE OF A PATIENT TO REPEATED COURSES OF ALKYLATING AGENTS.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune | 1963 |
DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING THE IMMUNE RESPONSE.
Topics: Allergy and Immunology; Antibody Formation; Antineoplastic Agents; Autoimmune Diseases; Cyclophospha | 1964 |